Lanzamiento Enero 2027

Ensayo controlado aleatorizado1990Financiación no declarada

Daytime sleepiness, performance, mood, nocturnal sleep: the effect of benzodiazepine and caffeine on their relationship

Johnson LC, Spinweber CL, Gomez SA, Matteson LT

Sleep · 35 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
1990-03-01 · Sleep · vol. 13 · número 2 · págs. 121–135
Editorial
Oxford University Press
Citado
68 citas · más que el 96% de estudios similares · 6.2× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
0 trabajos
Acceso
De pago
Áreas de investigación
Sleep and Work-Related Fatigue · Sleep and related disorders · Sleep and Wakefulness Research
Palabras clave
daytime sleepiness, nocturnal sleep, benzodiazepines, caffeine, flurazepam, triazolam, subjective sleepiness, mood, cognitive performance, sleep efficiency, multiple sleep latency test, Stanford Sleepiness Scale, Profile of Mood States
MeSH
humans, benzodiazepines, caffeine, double-blind method, affect, psychomotor performance, wakefulness, sleep, sleep stages, psychological tests, adolescent, adult, male, randomized controlled trials as topic

4 autores

  • L. C. Johnson🇺🇸 · autor de correspondenciaNaval Health Research Center
  • Cheryl L. Spinweber🇺🇸Naval Health Research Center
  • Steven A. Gomez🇺🇸Naval Health Research Center
  • Larry T. Matteson🇺🇸Naval Health Research Center

Resumen

El texto original del estudio, en el idioma en que se publicó.

The present study was part of a larger 3-day, 2-night double-blind parallel group design in which 80 young adult men were divided into eight treatment groups to examine the effects of benzodiazepines and caffeine on nocturnal sleep and daytime sleepiness, performance, and mood. The present study was done to examine further the relationship among daytime sleepiness, performance, mood, and nocturnal sleep and to determine if and how these relationships were affected by the nighttime use of benzodiazepine and the ingestion of caffeine in the morning. Subjects received 15 or 30 mg of flurazepam, 0.25 or 0.50 mg of triazolam, or placebo at bedtime and 250 mg of caffeine or placebo in the morning for two treatment days. Two objective (Multiple Sleep Latency Test and lapses) and two subjective (Stanford Sleepiness Scale and Visual Analog Scale) measures of sleepiness, five performance tests, and two mood measures (Profile of Mood Scale and Visual Analog Scale) were administered repeatedly on both days. Electroencephalogram sleep was recorded on both nights. Objective sleep measures of daytime sleepiness were not significantly related to either performance or mood, but subjects with greater daytime sleepiness had significantly longer and more efficient nocturnal sleep. Neither benzodiazepine or caffeine influenced these relationships. In contrast, higher estimates of subjective sleepiness were significantly associated with poorer mood and tended to be related to poorer performance. Caffeine significantly reduced these relationships. Nocturnal sleep measures were not related to subjective estimates of daytime sleepiness.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.